- Home
- KSCP vs PRLD Comparison
KSCP vs PRLD Comparison
Compare KSCP & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KSCP
- PRLD
- Stock Information
- Founded
- KSCP 2013
- PRLD 2016
- Country
- KSCP United States
- PRLD United States
- Employees
- KSCP N/A
- PRLD N/A
- Industry
- KSCP Telecommunications Equipment
- PRLD Medicinal Chemicals and Botanical Products
- Sector
- KSCP Telecommunications
- PRLD Health Care
- Exchange
- KSCP Nasdaq
- PRLD Nasdaq
- Market Cap
- KSCP 55.9M
- PRLD 53.4M
- IPO Year
- KSCP 2022
- PRLD 2020
- Fundamental
- Price
- KSCP $14.35
- PRLD $1.40
- Analyst Decision
- KSCP Strong Buy
- PRLD Strong Buy
- Analyst Count
- KSCP 1
- PRLD 2
- Target Price
- KSCP $200.00
- PRLD $4.50
- AVG Volume (30 Days)
- KSCP 158.5K
- PRLD 733.8K
- Earning Date
- KSCP 11-14-2024
- PRLD 02-13-2025
- Dividend Yield
- KSCP N/A
- PRLD N/A
- EPS Growth
- KSCP N/A
- PRLD N/A
- EPS
- KSCP N/A
- PRLD N/A
- Revenue
- KSCP $11,005,000.00
- PRLD $3,000,000.00
- Revenue This Year
- KSCP N/A
- PRLD N/A
- Revenue Next Year
- KSCP $41.67
- PRLD N/A
- P/E Ratio
- KSCP N/A
- PRLD N/A
- Revenue Growth
- KSCP N/A
- PRLD N/A
- 52 Week Low
- KSCP $4.89
- PRLD $0.80
- 52 Week High
- KSCP $35.75
- PRLD $6.80
- Technical
- Relative Strength Index (RSI)
- KSCP 47.54
- PRLD 64.52
- Support Level
- KSCP $11.75
- PRLD $1.14
- Resistance Level
- KSCP $14.70
- PRLD $1.59
- Average True Range (ATR)
- KSCP 1.40
- PRLD 0.16
- MACD
- KSCP -0.06
- PRLD 0.07
- Stochastic Oscillator
- KSCP 54.74
- PRLD 76.04
About KSCP Knightscope Inc.
Knightscope Inc is an advanced security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.